logo

For the Inventor, By the Inventor

La Jolla, CA, United States of America

Theodore S Zimmerman

This inventor holds 20 USPTO granted patents, plus 1 CIPO patent, primarily in Blood Coagulation. Top assignees: Scripps Clinic and Research Foundation, Rorer Biotechnology Inc., Scripps Research Institute. Active years: 1982-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Theodore S Zimmerman. Retrieved from https://idiyas.com/inventor/theodore-s-zimmerman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20

% Patents Active = 100.0


Average Co-Inventor Count = 2.1

ph-index = 10

Forward Citations = 344(Granted Patents)


Location History:

  • West Caldwell, NJ (US) (1992)
  • La Jolla, CA (US) (1982 - 1998)

Company Filing History:

goldMedal17 out of 122 
 
Scripps Clinic and Research Foundation
 patents
silverMedal2 out of 3 
 
Rorer Biotechnology Inc.
 patents
bronzeMedal2 out of 1,208 
 
Scripps Research Institute
 patents
4. 1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1982-1998

Loading Chart...
Loading Chart...
Areas of Expertise:
Factor VIII
Coagulant Polypeptides
Monoclonal Antibodies
Von Willebrand Factor
Recombinant Fragments
Blood Proteins
Ultrapurification
Platelet Inhibitors
Immunoaffinity Columns
Vitamin K-dependent Proteins
Binding Domains
Peptide Inhibitors
20 patents (USPTO):Explore Patents
1. 5747337 - Factor VIII coagulant polypeptides and monoclonal antibodies to them (1998-05-05),
2. 5597711 - Factor VIII binding domain of von Willebrand factor (1997-01-28),
3. 5362854 - Factor VIII coagulant polypeptides: method of making (1994-11-08),
4. 5260274 - Factor VIII binding domain of von Willebrand Factor (1993-11-09),
5. 5238919 - Peptides that inhibit von Willebrand Factor binding to the platelet SPIB (1993-08-24),
6. 5214033 - Factor VIII coagulant polypeptides (1993-05-25),
7. 5149637 - Recombinant Factor VIIIC fragments (1992-09-22),
8. 5131313 - Linear accelerator (1992-07-21),
9. 5101016 - Factor VIII coagulant polypeptides and monoclonal antibodies to them (1992-03-31),
10. 5055557 - Ultrapurification of factor IX and other vitamin K-dependent proteins (1991-10-08),
11. 5043429 - Protein fragments containing Factor VIII binding domain of von (1991-08-27),
12. 4980456 - Recombinant factor VIIIC derived fragments (1990-12-25),
13. 4886876 - Factor VIII coagulant polypeptides (1989-12-12),
14. 4857635 - Factor VIII coagulant polypeptides and monoclonal antibodies tof them (1989-08-15),
15. 4831118 - Flouroplastic immunoaffinity columns for purification of blood proteins (1989-05-16),

Title: The Innovative Journey of Theodore S. Zimmerman

Introduction: Theodore S. Zimmerman, a distinguished inventor hailing from La Jolla, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Zimmerman's latest patents include a cutting-edge wearable device for monitoring health metrics in real-time and a revolutionary software algorithm designed to enhance cybersecurity measures for businesses.

Career Highlights: With a career spanning over two decades, Zimmerman has established himself as a visionary in the tech industry. His innovative solutions have garnered widespread acclaim and have been instrumental in shaping the future of digital technology.

Collaborations: Throughout his career, Zimmerman has collaborated with leading tech companies and research institutions to further develop and refine his inventions. His collaborative spirit and dedication to excellence have led to the successful implementation of his groundbreaking ideas.

Conclusion: Theodore S. Zimmerman's relentless pursuit of innovation and commitment to technological advancement have solidified his reputation as a trailblazer in the field of inventing. His remarkable contributions continue to inspire future generations of inventors and shape the landscape of modern technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…